TipRanks
Advertisement
Advertisement
Guardian Pharmacy reports Q2 adjusted EPS 29c, consensus 26c
PremiumThe FlyGuardian Pharmacy reports Q2 adjusted EPS 29c, consensus 26c
1M ago
Guardian Pharmacy raises FY26 revenue view to $1.43B-$1.45B from $1.4B-$1.42B
Premium
The Fly
Guardian Pharmacy raises FY26 revenue view to $1.43B-$1.45B from $1.4B-$1.42B
1M ago
Guardian Pharmacy acquires Wellness Concepts, terms not disclosed
Premium
The Fly
Guardian Pharmacy acquires Wellness Concepts, terms not disclosed
3M ago
Allen Lutz Reiterates Buy on Guardian, Lifts Price Target to $47 on Strengthened Long-Term Growth Conviction
PremiumRatingsAllen Lutz Reiterates Buy on Guardian, Lifts Price Target to $47 on Strengthened Long-Term Growth Conviction
3M ago
Guardian Pharmacy management to meet with Oppenheimer
Premium
The Fly
Guardian Pharmacy management to meet with Oppenheimer
3M ago
Guardian Pharmacy Extends Revolving Credit Facility and Flexibility
Premium
Company Announcements
Guardian Pharmacy Extends Revolving Credit Facility and Flexibility
4M ago
Guardian Pharmacy reports Q1 EPS 29c, consensus 24c
PremiumThe FlyGuardian Pharmacy reports Q1 EPS 29c, consensus 24c
4M ago
Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
Premium
The Fly
Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
4M ago
Guardian Pharmacy initiated with a Buy at BofA
Premium
The Fly
Guardian Pharmacy initiated with a Buy at BofA
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100